Nuo Therapeutics, Inc.
AURX
$1.74
$0.2113.73%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 484.40K | 394.90K | 371.00K | 364.80K | 234.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 484.40K | 394.90K | 371.00K | 364.80K | 234.60K |
| Cost of Revenue | 121.00K | 86.40K | 100.50K | 65.30K | 50.60K |
| Gross Profit | 363.40K | 308.50K | 270.40K | 299.40K | 184.00K |
| SG&A Expenses | 1.11M | 937.70K | 847.80K | 841.40K | 893.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.23M | 1.02M | 948.30K | 906.80K | 943.80K |
| Operating Income | -745.10K | -629.20K | -577.40K | -542.00K | -709.20K |
| Income Before Tax | -746.10K | -496.70K | -578.20K | -540.10K | -708.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -746.10K | -496.70K | -578.20K | -540.10K | -708.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -746.10K | -496.70K | -578.20K | -540.10K | -708.80K |
| EBIT | -745.10K | -629.20K | -577.40K | -542.00K | -709.20K |
| EBITDA | -729.80K | -617.70K | -573.40K | -538.20K | -705.50K |
| EPS Basic | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 46.82M | 47.18M | 45.61M | 44.66M | 44.24M |
| Average Diluted Shares Outstanding | 46.82M | 47.18M | 45.61M | 44.66M | 44.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |